---
title: "MDxHealth climbs 10% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304299847.md"
description: "MDxHealth rose 10.42% to US$0.1749. Down 18.62% over ten sessions and down 95.10% YTD."
datetime: "2026-11-04T14:39:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304299847.md)
  - [en](https://longbridge.com/en/news/304299847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304299847.md)
generator: "portal-rs"
---

# MDxHealth climbs 10% during regular trading

MDxHealth (MDXH.US) climbed more than **10%** during regular trading to **$0.1749**.

The stock is down 18.62% over the past ten sessions and down 95.10% year to date. Volume was 7.69 times its average.

The Nasdaq Composite is down 2.94% over the past five sessions and up 10.88% year to date.

The biotechnology industry index rose 1.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [MDXH.US](https://longbridge.com/en/quote/MDXH.US.md)

## Related News & Research

- [MDxHealth Files 2026 Interim Report as Losses Deepen but Fresh Capital Extends Runway](https://longbridge.com/en/news/297967573.md)
- [Cadence Design Systems (CDNS) Launches New AI Tools, Is It Still 20% Undervalued?](https://longbridge.com/en/news/305521888.md)
- [Micron Stock (MU) Forecast – Why Are Analysts Bullish Despite Ongoing Volatility?](https://longbridge.com/en/news/305555924.md)
- [AI/ML Innovations Announces Annual General and Special Shareholder Meeting](https://longbridge.com/en/news/305516137.md)
- [Biocure Technology Inc. (CURE.X) Cuts Acquisition Shares to 11.3M, Extends Deadline](https://longbridge.com/en/news/305520627.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**